News | July 08, 2008

Confirma Offers CME Programs for Breast MRI

July 9, 2008 — Confirma is expanding customer support by providing increased access to CME-accredited educational programs for physicians to meet the growing demand for breast MRI.

Confirma supports professional development in breast MRI through educational grants to organizations, including the International Center for Postgraduate Medical Education (ICPME) and The Scienomics Group. Education programs consist of a variety of online case review seminars, fellowships, and didactic and hands-on training workshops.

The hands-on courses, supported by Confirma, are intended to educate physicians and technologists who offer breast MRI examinations and perform MRI-guided breast biopsies. Educational objectives include: assessing the clinical role of breast MRI in patient selection and the detection, diagnosis and management of breast disease; developing standardized post-processing techniques to determine the morphology and kinetics of lesions in breast MRI; and accurately interpreting and reporting breast MR images in accordance with the ACR BI-RADS. Participants also have the opportunity to review cases using CAD and practice MRI-guided biopsy techniques using a breast biopsy system.

Confirma is also providing a grant along with Bayer Healthcare for a new educational program, Breast MRI Interpretation for Radiologists, led by Constance D. Lehman, M.D., Ph.D., director of radiology at the Seattle Cancer Care Alliance and professor of radiology at the University of Washington, and Gillian M. Newstead, M.D., professor of radiology and director of breast imaging at the University of Chicago.

For more information: http://www.confirma.com/edu-train_calendar.html

Related Content

Artificial Intelligence Performs As Well As Experienced Radiologists in Detecting Prostate Cancer
News | Artificial Intelligence | April 18, 2019
University of California Los Angeles (UCLA) researchers have developed a new artificial intelligence (AI) system to...
Oxipit Introduces Multilingual Support for ChestEye AI Imaging Suite
News | Artificial Intelligence | April 16, 2019
The CE-certified ChestEye artificial intelligence (AI) imaging suite by Oxipit is now available in seven European...
iCAD Appoints Stacey Stevens as President
News | Radiology Business | April 16, 2019
iCAD Inc. recently announced that Stacey Stevens has been named president. As president, Stevens will have expanded...
Enlitic Closes Series B Funding for Artificial Intelligence Solutions for Radiologists
News | Artificial Intelligence | April 08, 2019
Radiology artificial intelligence (AI) company Enlitic announced the close of its $15 million Series B financing round...
iCAD Highlighting ProFound AI for Tomosynthesis at 2019 SBI Annual Symposium
News | Computer-Aided Detection Software | April 04, 2019
iCAD announced it will present its latest artificial intelligence (AI) software solution for digital breast...
A smart algorithm developed by iCAD

A smart algorithm developed by iCAD outlines and scores a suspicious lesion seen in an image created using digital breast tomography. Displayed is the probability calculated by the algorithm that the outlined area includes a cancerous lesion. Image courtesy of Emily Conant, M.D.

Feature | Artificial Intelligence | April 03, 2019 | Greg Freiherr
  Editor's Note: This article was updated following the SBI symposium.  
Siemens Healthineers Debuts AI-Rad Companion Chest CT
News | Artificial Intelligence | January 25, 2019
Siemens Healthineers presented its first intelligent software assistant for radiology, the AI-Rad Companion Chest CT,...
Telerad Tech Launches MammoAssist AI Software
Technology | Computer-Aided Detection Software | January 25, 2019
Telerad Tech recently announced the launch of MammoAssist, a new artificial intelligence (AI) product to analyze and...
Videos | Artificial Intelligence | December 13, 2018
ITN Editor Dave Fornell and ITN Contributing Editor Greg Freiherr share their insights on the vendors showing...
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...